Takeda Pharmaceutical Company Limited (TAK)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Oct 29, 2026
Consensus estimate row
EPS target
$0.14
Street estimate
Revenue target
$7.28B
Street estimate
Trailing EPS (avg 4Q)
$0.09
Beat rate last 4: 25%
Latest EPS YoY
-56.7%
vs 2025-07-30
Latest revenue YoY
+4.2%
How results look so far
Trailing revenue (avg 4Q)
$7.38B
Printed quarters
EPS beat rate (4Q)
25%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Jul 30, 2026
EPS beat
EPS actual / est
$0.23 / $0.17
+33.2%
Revenue actual / est
$7.66B / $7.13B
+7.4%
Result
Target reached
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 10/29/2026upcoming | $0.14 | Pending | — | $7.28B | Pending | — |
| 7/30/2026 | $0.17 | $0.23 | +33.2% | $7.13B | $7.66B | +7.4% |
| 5/13/2026 | $0.21 | $-0.05 | -123.4% | $7.14B | $6.92B | -3.0% |
| 1/29/2026 | $0.55 | $0.21 | -61.3% | $7.54B | $7.73B | +2.5% |
| 10/30/2025 | $0.44 | $-0.02 | -105.7% | $7.79B | $7.22B | -7.3% |
| 7/30/2025 | $0.47 | $0.52 | +10.6% | $8.02B | $7.35B | -8.3% |
| 6/25/2025 | — | $-0.22 | — | — | $7.24B | — |
| 5/8/2025 | $0.24 | $-0.22 | -193.5% | $7.36B | $7.26B | -1.2% |
| 1/30/2025 | $0.34 | $0.05 | -85.6% | $7.36B | $7.39B | +0.4% |
| 10/31/2024 | $0.39 | $0.19 | -51.0% | $7.45B | $7.69B | +3.2% |
| 7/31/2024 | $0.37 | $0.20 | -45.1% | $6.98B | $8.05B | +15.3% |
| 5/9/2024 | $0.00 | $-0.01 | -339.3% | $6.06B | $6.74B | +11.2% |
| 2/1/2024 | $0.10 | $0.23 | +133.9% | $6.76B | $7.49B | +10.8% |
| 10/26/2023 | $0.10 | $-0.10 | -207.2% | $6.75B | $6.97B | +3.2% |
| 7/27/2023 | $0.14 | $0.20 | +44.5% | $7.12B | $7.54B | +6.0% |
| 5/11/2023 | $0.05 | $0.08 | +49.7% | $7.16B | $7.07B | -1.3% |
| 2/2/2023 | $0.28 | $0.46 | +62.1% | $7.45B | $8.37B | +12.4% |
| 10/27/2022 | $0.13 | $0.52 | +289.2% | $6.78B | $6.79B | +0.2% |
| 7/28/2022 | $0.24 | $0.56 | +135.8% | $6.93B | $7.28B | +5.1% |
| 5/11/2022 | $0.06 | $0.38 | +527.1% | $6.94B | $6.75B | -2.6% |